Neuromedin U in the tumor microenvironment - Possible actions in tumor progression
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
DOI: 10.1016/j.bbcan.2025.189269 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von Patrycja Przygodzka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa Str., 93-232 Lodz, Poland. Electronic address: pprzygodzka@cbm.pan.pl. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Neuropeptides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre Poland.
Abstract (Originalsprache)
Tumor microenvironment (TME) has become a major focus of cancer research as a promising therapeutic target. TME comprises cancer cells surrounded by nonmalignant cells, vessels, lymphoid organs, immune cells, nerves, intercellular components, molecules and metabolites located within or near the tumor lesion. Neuromedin U (NMU), a secretory peptide identified in the TME, has gained much attention as an important player in cancer and nonmalignant cell crosstalk. NMU receptors were detected in cancer cells as well as in nonmalignant TME components, such as immune, stromal and endothelial cells. We propose here to discuss the concept that NMU secreted by cancer cells activates cellular components of TME and thus contributes to the formation of microenvironment that favors tumor growth and cancer progression. We summarized the available data on cancer tissues and cell types that have been identified as a source of NMU and/or receptor-expressing NMU targets. We made a critical selection of NMU-receptor positive cell types that are known components of the TME of most malignant tumors. Finally, we discussed whether NMUs and NMU receptors represent a potential therapeutic target for cancer treatment, and summarized information on the tools available to modulate their activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa Str., 93-232 Lodz, Poland. Electronic address: pprzygodzka@cbm.pan.pl.
- Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa Str., 93-232 Lodz, Poland.
- Silesian University of Technology, Department of Systems Biology and Engineering, 16 Akademicka Str., 44-100 Gliwice, Poland.
Förderung
- National Science Centre Poland
Zitieren
APA
Przygodzka, P., Szulc-Kielbik, I., Kielbik, M., Pacholczyk, M., & Klink, M. (2025). Neuromedin U in the tumor microenvironment - Possible actions in tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189269
Vancouver
Przygodzka P, Szulc-Kielbik I, Kielbik M, Pacholczyk M, Klink M. Neuromedin U in the tumor microenvironment - Possible actions in tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189269
BibTeX
@article{Przygodzka2025,
author = {Przygodzka, Patrycja and Szulc-Kielbik, Izabela and Kielbik, Michal and Pacholczyk, Marcin and Klink, Magdalena},
title = {Neuromedin U in the tumor microenvironment - Possible actions in tumor progression},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
doi = {10.1016/j.bbcan.2025.189269}
}
EUVIMED